Liminatus Pharma LIMN
NASDAQ LIMN
$3.90 +0.11 (+2.90%)
At close: Oct 2, 2026 · 4:00 PM EDT

Liminatus Pharma (LIMN) Other Accumulated Expenses (2024 - 2026)

Updated

Liminatus Pharma's Other Accumulated Expenses was $201,431 in Q2 2026, up 16.6% from $172,753 a year earlier and up 3.5% from the prior quarter.

Analysis

Liminatus Pharma (LIMN) Other Accumulated Expenses (2024 - 2026) Analysis & Trends

At the end of FY2025, Other Accumulated Expenses at Liminatus Pharma came in at $209,586, down 89.4% from FY2024.

  • In earlier years, Other Accumulated Expenses was $1.98 million in FY2024.
  • Quarterly Other Accumulated Expenses has moved between $172,753 (Q2 2025) and $1.98 million (Q4 2024) over five years.
  • Per Business Quant data, LIMN's Other Accumulated Expenses in the three quarters before Q2 2026 was $194,587 (Q1 2026), $209,586 (Q4 2025) and $180,253 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Liminatus Pharma 4.37 Mn 4.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 201,431.00
Mar 31, 2026 194,587.00
Dec 31, 2025 209,586.00
Sep 30, 2025 180,253.00
Jun 30, 2025 172,753.00
Dec 31, 2024 1.98 Mn
API Access

Liminatus Pharma Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=LIMN&period=max&api_key=YOUR_API_KEY